Therefore, COL1A1 and COL1A2 are recognized as key molecular markers for MASLD fibrosis, and their expression levels can be used to assess hepatic fibrosis severity and predict therapeutic responses.41 This evidence concerns the gene COL1A2 and fibrosis.